Plato Data Intelligence.
Vertical Search & Ai.

Tag: Immune System

New Immuno-Oncology Research Project in Partnership With Merck Starts at the BioMed X Institute in Heidelberg

HEIDELBERG, Germany, Apr 30, 2024 - (ACN Newswire) - BioMed X, a German biomedical research institute, announces the start of a new research project...

Top News

Cell Therapies Now Beat Back Once Untreatable Blood Cancers. Scientists Are Making Them Even Deadlier.

Dubbed “living drugs,” CAR T cells are bioengineered from a patient’s own immune cells to make them better able to hunt and destroy cancer.The...

This Company Is Growing Mini Livers Inside People to Fight Liver Disease

Growing a substitute liver inside a human body sounds like science fiction.Yet a patient with severe liver damage just received an injection that could...

Viruses Finally Reveal Their Complex Social Life | Quanta Magazine

IntroductionEver since viruses came to light in the late 1800s, scientists have set them apart from the rest of life. Viruses were far smaller...

Transgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at AACR 2024

TOKYO, Apr 10, 2024 - (JCN Newswire) - Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment...

A New Treatment Rejuvenates Aging Immune Systems in Elderly Mice

Our immune system is like a well-trained brigade.Each unit has a unique specialty. Some cells directly kill invading foes; others release protein “markers” to...

Cell Therapy Takes Aim at Deadly Brain Tumors in Two Clinical Trials

When my uncle was diagnosed with glioblastoma, I knew he was on borrowed time.The deadliest form of brain cancer, it rapidly spreads through the...

Irresistible: Hooks, habits and why you can’t put down your phone

How often do you go somewhere without your phone? And how do you feel when you go somewhere with no signal? Let’s be honest,...

Transgene, NEC, and BostonGene Expand Collaboration for Phase I/II Clinical Trial of Neoantigen Cancer Vaccine TG4050

Strasbourg (France), Tokyo (Japan) and Waltham, Mass, Mar 5, 2024 - (JCN Newswire) - Transgene (Euronext Paris: TNG), a biotech company that designs and...

Singaporeans are Armouring Up Against Viral Infections and Diseases with LAC’s Immunity Arsenal

SINGAPORE, Mar 4, 2024 - (ACN Newswire) - The importance of a robust immune system cannot be overstated—it serves as our body's frontline defence...

An Antibiotic You Inhale Can Deliver Medication Deep Into the Lungs

We’ve all been more aware of lung health since Covid-19.However, for people with asthma and chronic obstructive pulmonary disease (COPD), dealing with lung problems...

A One-and-Done Injection to Slow Aging? New Study in Mice Opens the Possibility

A preventative anti-aging therapy seems like wishful thinking.Yet a new study led by Dr. Corina Amor Vegas at Cold Spring Harbor Laboratory describes a...

Aviceda Therapeutics Announces First Patient Dosed in Part 2 of the Phase 2/3 SIGLEC Clinical Trial Assessing AVD-104 for the Treatment of Geographic Atrophy

Part 2 of the Phase 2/3 SIGLEC clinical trial is designed and powered to serve as the first pivotal trial to support approval of...

Latest Intelligence

spot_img
spot_img
spot_img

Chat with us

Hi there! How can I help you?